nepafenac 3 MG/ML Ophthalmic Suspension

RxCUI: 1362132
RxNorm name: nepafenac 3 MG/ML Ophthalmic Suspension
Display name: nepafenac 3 MG/ML Ophthalmic Suspension
Full name: nepafenac 3 MG/ML Ophthalmic Suspension
Term type: SCD
Status: DailyMed mapping
Updated: 2026-06-04 23:39:27

RxNav Current And Historical NDCs#

RxNav current and historical NDC rows page 1 of 1 · 0 matching rows.

No records found.

UNII Substances#

UNII substance links page 1 of 1 · 0 matching rows.

No records found.

openFDA label cross-check#

Cross-check layer: openFDA label JSON enriches search and identifies hydration gaps. The DailyMed Structured Product Label remains the canonical label presentation on FDA.report. Every label matching the complete exact-identifier union is deduplicated and paginated below.

Matched openFDA labels page 1 of 1 · 2 matching rows.

Brand, Generic, Manufacturer table
Brand	Generic	Manufacturer	SPL set ID	Effective date	Available safety fields	Join
ILEVRO	NEPAFENAC	Novartis Pharmaceuticals Corporation	f089b583-0310-4ca8-8d41-52b06b08d1ed	2026-04-01	Warnings, Adverse reactions	Exact identifier rxcui: 1362132
ILEVRO	NEPAFENAC	Harrow Eye, LLC	10f411d3-a81e-074a-e063-6294a90ab547	2026-04-01	Warnings, Adverse reactions	Exact identifier rxcui: 1362132

DailyMed RxNorm Mappings#

Set ID, RxNorm string, TTY table
Set ID	RxNorm string	TTY	SPL version	Label	Effective
10f411d3-a81e-074a-e063-6294a90ab547	nepafenac 0.3 % Ophthalmic Suspension	PSN	5	These highlights do not include all the information needed to use ILEVRO ® safely and effectively. See full prescribing information for ILEVRO. ILEVRO ® (nepafenac ophthalmic suspension), topical ophthalmic Initial U.S. Approval: 2005	20260401
10f411d3-a81e-074a-e063-6294a90ab547	nepafenac 3 MG/ML Ophthalmic Suspension	SCD	5	These highlights do not include all the information needed to use ILEVRO ® safely and effectively. See full prescribing information for ILEVRO. ILEVRO ® (nepafenac ophthalmic suspension), topical ophthalmic Initial U.S. Approval: 2005	20260401
10f411d3-a81e-074a-e063-6294a90ab547	nepafenac 0.3 % Ophthalmic Suspension	SY	5	These highlights do not include all the information needed to use ILEVRO ® safely and effectively. See full prescribing information for ILEVRO. ILEVRO ® (nepafenac ophthalmic suspension), topical ophthalmic Initial U.S. Approval: 2005	20260401
f089b583-0310-4ca8-8d41-52b06b08d1ed	nepafenac 0.3 % Ophthalmic Suspension	SY	5	These highlights do not include all the information needed to use ILEVRO ® safely and effectively. See full prescribing information for ILEVRO. ILEVRO ® (nepafenac ophthalmic suspension), topical ophthalmic Initial U.S. Approval: 2005	20260401
f089b583-0310-4ca8-8d41-52b06b08d1ed	nepafenac 0.3 % Ophthalmic Suspension	PSN	5	These highlights do not include all the information needed to use ILEVRO ® safely and effectively. See full prescribing information for ILEVRO. ILEVRO ® (nepafenac ophthalmic suspension), topical ophthalmic Initial U.S. Approval: 2005	20260401
f089b583-0310-4ca8-8d41-52b06b08d1ed	nepafenac 3 MG/ML Ophthalmic Suspension	SCD	5	These highlights do not include all the information needed to use ILEVRO ® safely and effectively. See full prescribing information for ILEVRO. ILEVRO ® (nepafenac ophthalmic suspension), topical ophthalmic Initial U.S. Approval: 2005	20260401